Literature DB >> 26503489

Evaluation of a 7-Methoxycoumarin-3-carboxylic Acid Ester Derivative as a Fluorescent, Cell-Cleavable, Phosphonate Protecting Group.

Andrew J Wiemer1, Rebekah R Shippy2, Ashley M Kilcollins3, Jin Li1, Chia-Hung Christine Hsiao1, Rocky J Barney4, M Lei Geng5, David F Wiemer6.   

Abstract

Cell-cleavable protecting groups often enhance cellular delivery of species that are charged at physiological pH. Although several phosphonate protecting groups have achieved clinical success, it remains difficult to use these prodrugs in live cells to clarify biological mechanisms. Here, we present a strategy that uses a 7-methoxycoumarin-3-carboxylic acid ester as a fluorescent protecting group. This strategy was applied to synthesis of an (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate (HMBPP) analogue to assess cellular uptake and human Vγ9Vδ2 T cell activation. The fluorescent ester displayed low cellular toxicity (IC50 >100 μm) and strong T cell activation (EC50 =0.018 μm) relative to the unprotected anion (EC50 =23 μm). The coumarin-derived analogue allowed no-wash analysis of biological deprotection, which revealed rapid internalization of the prodrug. These results demonstrate that fluorescent groups can be applied both as functional drug delivery tools and useful biological probes of drug uptake.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  antigens; butyrophilin; coumarin; phosphorus; prodrugs

Mesh:

Substances:

Year:  2015        PMID: 26503489      PMCID: PMC4746711          DOI: 10.1002/cbic.201500484

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  23 in total

1.  Fluorescently labeled risedronate and related analogues: "magic linker" synthesis.

Authors:  Boris A Kashemirov; Joy Lynn F Bala; Xiaolan Chen; F H Ebetino; Zhidao Xia; R Graham G Russell; Fraser P Coxon; Anke J Roelofs; Michael J Rogers; Charles E McKenna
Journal:  Bioconjug Chem       Date:  2008-12       Impact factor: 4.774

Review 2.  Prodrugs of phosphonates and phosphates: crossing the membrane barrier.

Authors:  Andrew J Wiemer; David F Wiemer
Journal:  Top Curr Chem       Date:  2015

3.  Opportunities and challenges in development of phosphoantigens as Vγ9Vδ2 T cell agonists.

Authors:  David F Wiemer; Andrew J Wiemer
Journal:  Biochem Pharmacol       Date:  2014-03-26       Impact factor: 5.858

4.  Metabolism of GS-7340, a novel phenyl monophosphoramidate intracellular prodrug of PMPA, in blood.

Authors:  E J Eisenberg; G X He; W A Lee
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2001 Apr-Jul       Impact factor: 1.381

5.  Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA.

Authors:  B L Robbins; R V Srinivas; C Kim; N Bischofberger; A Fridland
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

6.  Synthesis and antitumor evaluation of bis[(pivaloyloxy)methyl] 2'-deoxy-5-fluorouridine 5'-monophosphate (FdUMP): a strategy to introduce nucleotides into cells.

Authors:  D Farquhar; S Khan; D N Srivastva; P P Saunders
Journal:  J Med Chem       Date:  1994-11-11       Impact factor: 7.446

7.  Synthesis of acyloxymethyl ester prodrugs of the transferable protein farnesyl transferase substrate farnesyl methylenediphosphonate.

Authors:  Jerry M Troutman; Kareem A H Chehade; Katarzyna Kiegiel; Douglas A Andres; H Peter Spielmann
Journal:  Bioorg Med Chem Lett       Date:  2004-10-04       Impact factor: 2.823

8.  Pivaloyloxymethyl-modified isoprenoid bisphosphonates display enhanced inhibition of cellular geranylgeranylation.

Authors:  Andrew J Wiemer; Jose S Yu; Larry W Shull; Rocky J Barney; Brian M Wasko; Kimberly M Lamb; Raymond J Hohl; David F Wiemer
Journal:  Bioorg Med Chem       Date:  2008-02-08       Impact factor: 3.641

9.  Measurement of transmembrane potentials in phospholipid vesicles.

Authors:  R D Kornberg; M G McNamee; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

Review 10.  The Vγ9Vδ2 T Cell Antigen Receptor and Butyrophilin-3 A1: Models of Interaction, the Possibility of Co-Evolution, and the Case of Dendritic Epidermal T Cells.

Authors:  Mohindar M Karunakaran; Thomas Herrmann
Journal:  Front Immunol       Date:  2014-12-19       Impact factor: 7.561

View more
  7 in total

1.  A power law function describes the time- and dose-dependency of Vγ9Vδ2 T cell activation by phosphoantigens.

Authors:  Chia-Hung Christine Hsiao; Andrew J Wiemer
Journal:  Biochem Pharmacol       Date:  2018-11-02       Impact factor: 5.858

2.  Stability and Efficiency of Mixed Aryl Phosphonate Prodrugs.

Authors:  Benjamin J Foust; Jin Li; Chia-Hung Christine Hsiao; David F Wiemer; Andrew J Wiemer
Journal:  ChemMedChem       Date:  2019-07-24       Impact factor: 3.466

3.  Phosphonamidate Prodrugs of a Butyrophilin Ligand Display Plasma Stability and Potent Vγ9 Vδ2 T Cell Stimulation.

Authors:  Nicholas A Lentini; Benjamin J Foust; Chia-Hung Christine Hsiao; Andrew J Wiemer; David F Wiemer
Journal:  J Med Chem       Date:  2018-09-26       Impact factor: 7.446

4.  Phosphinophosphonates and Their Tris-pivaloyloxymethyl Prodrugs Reveal a Negatively Cooperative Butyrophilin Activation Mechanism.

Authors:  Rebekah R Shippy; Xiaochen Lin; Sherry S Agabiti; Jin Li; Brendan M Zangari; Benjamin J Foust; Michael M Poe; Chia-Hung Christine Hsiao; Olga Vinogradova; David F Wiemer; Andrew J Wiemer
Journal:  J Med Chem       Date:  2017-03-01       Impact factor: 7.446

5.  Mixed Aryl Phosphonate Prodrugs of a Butyrophilin Ligand.

Authors:  Benjamin J Foust; Michael M Poe; Nicholas A Lentini; Chia-Hung Christine Hsiao; Andrew J Wiemer; David F Wiemer
Journal:  ACS Med Chem Lett       Date:  2017-08-09       Impact factor: 4.345

6.  Dual Fluorescence and Solvatochromic Study on 3-Acyl Coumarins.

Authors:  S Samundeeswari; M V Kulkarni; Jayashree Yenagi; J Tonannavar
Journal:  J Fluoresc       Date:  2017-04-03       Impact factor: 2.217

7.  Incorporation of a FRET pair within a phosphonate diester.

Authors:  Nyema M Harmon; Xueting Huang; Chia-Hung Christine Hsiao; Andrew J Wiemer; David F Wiemer
Journal:  Bioorg Chem       Date:  2021-05-30       Impact factor: 5.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.